Tag Archives: Ryan Starkes

BDO Biotech Briefing

Biotechs Continue to Invest More in R&D and Leverage the Capital Markets By:  Ryan Starkes Explore how recent BDO analysis revealed research and development spending at biotech firms and the utilization of capital markets to obtain the cash for R&D funding continues to rise. Continue Reading Advertisements

Continue Reading

Technology Company CFOs “Cautiously Optimistic” about 2012 Growth

By Ryan Starkes  Technology company CFOs are expressing an optimistic, albeit cautious, outlook for 2012 with a renewed focus on M&A and raising capital to supplement slightly lower revenue projections, according to the fifth- annual BDO Technology Outlook Survey.  The survey examined the opinions of 100 chief financial officers at leading technology companies throughout theU.S.about […]

Continue Reading

The Financial Landscape for New Jersey Biotech Companies

By Ryan Starkes As lifescience companies continue to work through the most recent wave of economic challenges, a study of bio-technology companies’ 2010 performance provides an indication of management’s evolving perspective on R&D spending. The 2011 BDO Biotech Briefing examined the most recent 10-K SEC filings of the publicly traded companies listed on the NASDAQ […]

Continue Reading